Download logo
Discussions centered on discovering, developing, and delivering safe, effective, and affordable vaccines for vulnerable populations worldwide.
The IVI's impactful strides in bolstering Korea's vaccine manufacturing, coupled with a strategic partnership between IVI and Kenya's BioVax Institute facilitated by the Kenyan government, signify a significant leap forward. This partnership focuses on technology transfer and manufacturing support, marking a monumental collaboration.
Kenya's commitment to hosting IVI's continental office underscores a promising future. This initiative is poised to forge crucial partnerships in technology and knowledge transfer, amplifying the nation’s readiness to combat vaccine-preventable diseases during outbreaks, epidemics, or pandemics.
Distributed by APO Group on behalf of Ministry of Health, Kenya.
This website uses cookies.